The COVID pandemic ushered mRNA vaccines into the spotlight, and the technology has even greater potential. Here’s what to ...

Researchers are advancing several norovirus vaccine candidates, such as oral tablet-based platforms, mRNA vaccines, and virus-like particle technologies.

After shedding expensive commercial infrastructure and pivoting to a partnership model, the company is now positioning its ...

Gronvall reminded the audience there are currently two vaccines that do work to prevent cancer: the hepatitis B vaccine given ...

The global influenza vaccines market is projected to reach USD 13.46 billion by 2031, growing at a CAGR of 7.49%, led by North America, with Asia-Pacific emerging as a high-growth region driven by ...

In the world of clinical trials, missing the primary endpoint of a pivotal trial typically spells real trouble for a drug ...

CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will ...

The Brahmanbaria MP said that the situation has become dire due to the gaps created in the regular vaccination programme in ...

Vaccines and other immune-based interventions are among the most effective strategies for preventing and controlling disease. However, their development is ...

None ...

A new vaccine to prevent Lyme disease in humans may soon be available. Pfizer said it's planning to seek regulatory approval.

Essential tools for understanding viral evolution, monoclonal anitbodies guide therapeutic development and inform vaccine ...